AIVITA Biomedical, Inc.

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields. AIVITA’s lead focus is on patient-specific vaccines for the treatment of advanced cancers and prevention of COVID-19.